Earthworm Protease Reduces Fibronectin and HBeAg in Liver Cells
Author Information
Author(s): Wang Xue-Qing, Chen Lan, Pan Rong, Zhao Jing, Liu Ying, He Rong-Qiao
Primary Institution: State Key Lab of Brain and Cognitive Sciences, Institute of Biophysics, the Chinese Academy of Sciences
Hypothesis
Can an earthworm protease effectively cleave fibronectin and reduce hepatitis B virus markers in liver cells?
Conclusion
The earthworm protease, EFNase, cleaves fibronectin rapidly and may inhibit HBV infection by lowering HBeAg levels.
Supporting Evidence
- The earthworm protease was shown to cleave fibronectin at specific sites.
- Oral administration of EFNase to rats significantly decreased serum fibronectin levels.
- EFNase treatment led to a significant reduction in HBeAg secretion from HepG2.2.15 cells.
Takeaway
Scientists found a special enzyme from earthworms that can break down a protein in our blood that helps viruses spread, which might help treat hepatitis B.
Methodology
The study used purified earthworm protease to digest serum proteins and tested its effects on fibronectin and HBV markers in rats and liver cells.
Potential Biases
Potential bias due to the use of animal models and the specific conditions under which the experiments were conducted.
Limitations
The study did not explore the long-term effects of EFNase or its potential side effects in humans.
Participant Demographics
Male Sprague-Dawley rats weighing 200–250 g were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website